(Q48435557)

English

An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition

scientific article published on 23 August 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16936704

An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16936704

tetrahydrocannabinol

0 references

0 references

1 reference

based on heuristic

inferred from title

8

object named as

Jim van Os

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

6

object named as

Marjan Drukker

0 references

Lydia Krabbendam

3

object named as

Lydia Krabbendam

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16936704

object named as

Araceli Rosa

2

0 references

Cécile Henquet

1

object named as

Cécile Henquet

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16936704

author name string

Sergi Papiol

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16936704

Lourdes Fananás

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16936704

Marjan Drukker

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16936704

Johannes G Ramaekers

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16936704

language of work or name

0 references

publication date

23 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16936704

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16936704

31

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16936704

12

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16936704

2748-2757

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16936704

The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Putatively psychosis-prone subjects 10 years later

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Sustained attention deficits as markers of genetic susceptibility to schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

COMT gene polymorphism is associated with declarative memory in adulthood and old age.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

The incidence and outcome of subclinical psychotic experiences in the general population.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

The environment and schizophrenia: the role of cannabis use.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Pathways to schizophrenia: the impact of environmental factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Deconstructing the familiality of the emotive component of psychotic experiences in the general population.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Repeated exposure to delta 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

The continuity of psychotic experiences in the general population.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

The genetics of schizophrenia: a current, genetic-epidemiologic perspective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Single or multiple familial cognitive risk factors in schizophrenia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Familial covariation of the subclinical psychosis phenotype and verbal fluency in the general population.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Quantitative analysis of delta9-tetrahydrocannabinol in preserved oral fluid by liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Neurochemical Sensitization in the Pathophysiology of Schizophrenia: Deficits and Dysfunction in Neuronal Regulation and Plasticity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Effect of an extract of cannabis and of some cannabinols on catecholamine metabolism in rat brain and heart

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

The structure of schizotypy: relationships between neurocognitive and personality disorder features in relatives of schizophrenic patients in the UCLA Family Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Dose related risk of motor vehicle crashes after cannabis use.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

An improved Bonferroni procedure for multiple tests of significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Studies of interference in serial verbal reactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Cannabis use and psychosis: a longitudinal population-based study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Strauss (1969) revisited: a psychosis continuum in the general population?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Prevalence of psychotic disorder and community level of psychotic symptoms: an urban-rural comparison.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Cannabis induced dopamine release: an in-vivo SPECT study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

21 January 2018

Catechol-O-methyltransferase genotype and dopamine regulation in the human brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

7 January 2021

based on heuristic

inferred from DOI database lookup

No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

7 January 2021

based on heuristic

inferred from DOI database lookup

Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high-enzyme activity val allele with adhd impulsive-hyperactive phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for instrument and family-specific variation of subclinical psychosis dimensions in the general population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated endogenous cannabinoids in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

7 January 2021

based on heuristic

inferred from DOI database lookup

Cannabis abuse and the course of recent-onset schizophrenic disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301197

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1301197

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16936704

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/16936704

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48435557&oldid=2209464419"